文献速递白血病

人急性白血病利用支链氨基酸分解代谢通过调控PRC2功能维持干性

Human acute leukemia uses branched-chain amino acid catabolism to maintain stemness through regulating PRC2 function.
PubMed 文献 · Blood Adv · 2023-01-01

该研究全面检测了正常造血干祖细胞、原发急性髓系白血病和急性淋巴细胞白血病CD34+细胞的代谢物,发现人急性白血病细胞依赖支链氨基酸(BCAA)代谢维持干性。BCAA剥夺可抑制白血病细胞扩增、植入和自我更新,BCAA分解代谢通过调控PRC2功能维持干性,相关分子或为治疗靶点。

要点

  • 人原发急性白血病细胞的BCAA转运体、BCAA、α-酮戊二酸和BCAT1水平显著高于对照造血干祖细胞。
  • 饮食剥夺BCAA可强烈抑制人急性白血病细胞的扩增、植入和自我更新。
  • 抑制BCAA分解代谢通过抑制PRC2组分转录特异性失活PRC2功能。

核心结论

  • BCAA分解代谢在原发人急性髓系白血病和急性淋巴细胞白血病干性维持中起重要作用,BCAA代谢通路相关分子应成为急性白血病治疗的关键靶点。

研究设计与样本

  • 研究综合测量了正常造血干祖细胞、原发人急性髓系白血病和急性淋巴细胞白血病细胞CD34+组分的细胞代谢物,并进行同位素示踪和异种移植实验。

主要发现

  • 人原发急性白血病细胞的BCAA转运体、细胞BCAA、α-酮戊二酸和细胞质BCAA转氨酶-1(BCAT1)水平显著高于对照造血干祖细胞。
  • 同位素示踪显示原发白血病细胞中BCAT1利用α-酮戊二酸将BCAA分解为支链α-酮酸,为三羧酸循环和非必需氨基酸合成提供底物,两者再生α-酮戊二酸以维持其细胞水平。
  • 异种移植实验中,每日饮食剥夺BCAA强烈抑制人急性白血病细胞的扩增、植入和自我更新。
  • 抑制原发急性髓系白血病或急性淋巴细胞白血病细胞的BCAA分解代谢,通过抑制PRC2组分(如zeste homolog 2和embryonic ectoderm development)的转录,特异性失活多梳抑制复合体2(PRC2)功能。

临床怎么用

  • 原文结论指出BCAA代谢通路相关分子应成为急性白血病治疗的关键靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cancer-specific metabolic activities play a crucial role in the pathogenesis of human malignancies. To investigate human acute leukemia-specific metabolic properties, we comprehensively measured the cellular metabolites within the CD34+ fraction of normal hematopoietic stem progenitor cells (HSPCs), primary human acute myelogenous leukemia (AML), and acute lymphoblastic leukemia (ALL) cells. Here, we show that human leukemia cells are addicted to the branched-chain amino acid (BCAA) metabolism to maintain their stemness, irrespective of myeloid or lymphoid types. Human primary acute leukemias had BCAA transporters for BCAA uptake, cellular BCAA, α-ketoglutarate (α-KG), and cytoplasmic BCAA transaminase-1 (BCAT1) at significantly higher levels than control HSPCs. Isotope-tracing experiments showed that in primary leukemia cells, BCAT1 actively catabolizes BCAA using α-KG into branched-chain α-ketoacids, whose metabolic processes provide leukemia cells with critical substrates for the trichloroacetic acid cycle and the synthesis of nonessential amino acids, both of which reproduce α-KG to maintain its cellular level. In xenogeneic transplantation experiments, deprivation of BCAA from daily diet strongly inhibited expansion, engraftment and self-renewal of human acute leukemia cells. Inhibition of BCAA catabolism in primary AML or ALL cells specifically inactivates the function of the polycomb repressive complex 2, an epigenetic regulator for stem cell signatures, by inhibiting the transcription of PRC components, such as zeste homolog 2 and embryonic ectoderm development. Accordingly, BCAA catabolism plays an important role in the maintenance of stemness in primary human AML and ALL, and molecules related to the BCAA metabolism pathway should be critical targets for acute leukemia treatment.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Kikushige Y, Miyamoto T, Kochi Y, et al. Human acute leukemia uses branched-chain amino acid catabolism to maintain stemness through regulating PRC2 function. Blood Adv. 2023. PMID: 36044390. doi:10.1182/bloodadvances.2022008242

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。